{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:12:49Z","timestamp":1788415969371,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess cardiometabolic control among patients with type 2 diabetes mellitus (T2DM) in Shanxi Province and identify variables associated with poor cardiometabolic control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data on demographic characteristics, medical history, Knowledge\u2013Attitude\u2013Practice (KAP) questionnaire scores, and clinical measurements of blood pressure, glucose, and lipid levels were collected from seven hospitals in Shanxi Province between June 2024 and June 2025. Poor cardiometabolic control was defined as failure to achieve comprehensive control across the three cardiometabolic domains (blood pressure, glycemia, and lipid levels), with failure to meet the target in any single domain considered poor control. Variable selection was performed using the least absolute shrinkage and selection operator (LASSO) combined with bootstrap-based stability selection. Firth\u2019s penalized logistic regression was then applied to the stably selected variables to estimate their associations with poor cardiometabolic control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1,874 patients, only 2.88% achieved comprehensive cardiometabolic control. Most patients had marked deficits in knowledge of blood pressure and lipid management, as well as in self-monitoring and symptom recognition. Bootstrap stability selection combined with Firth regression identified six candidate variables. Among these, BMI, education level, and knowledge score exhibited the strongest, nominally significant associations with poor cardiometabolic control, whereas practice score, hypertension history, and T2DM duration were selected but did not reach nominal significance. These exploratory findings require validation in independent cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cardiometabolic control among patients with T2DM in Shanxi Province remains suboptimal. Exploratory analyses suggest that BMI, education level, and knowledge score are the variables most robustly associated with poor cardiometabolic control, whereas practice score, hypertension history, and T2DM duration represent additional, weaker candidate associations warranting further investigation. These findings may inform future diabetes self-management education and intervention strategies aimed at improving glycemic, blood pressure, and lipid control. However, given the cross-sectional and exploratory nature of this study, the results should be regarded as hypothesis-generating and require confirmation in prospective or interventional studies before causal inferences can be drawn.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1905392","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:16:15Z","timestamp":1788412575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with poor cardiometabolic control in patients with type 2 diabetes: a Lasso-Firth penalized regression analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Wei","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Yuncheng Central Hospital Affiliated to Shanxi Medical University","place":["Yuncheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-shuai","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yuncheng Central Hospital Affiliated to Shanxi Medical University","place":["Yuncheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shanxi Province Hospital of Traditional Chinese Medicine","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jincheng People\u2019s Hospital","place":["Jincheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-fei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Heping Hospital, Changzhi Medical College","place":["Changzhi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yuncheng Central Hospital Affiliated to Shanxi Medical University","place":["Yuncheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yuncheng Central Hospital Affiliated to Shanxi Medical University","place":["Yuncheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-jun","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yuncheng Central Hospital Affiliated to Shanxi Medical University","place":["Yuncheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-feng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yuncheng Central Hospital Affiliated to Shanxi Medical University","place":["Yuncheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-hong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Linfen People\u2019s Hospital","place":["Linfen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-hong","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yangquan Coal Industry (Group) General Hospital","place":["Yangquan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Datong Tongmei Hospital","place":["Datong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yuncheng Central Hospital Affiliated to Shanxi Medical University","place":["Yuncheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Yuncheng Central Hospital Affiliated to Shanxi Medical University","place":["Yuncheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Yuncheng Central Hospital Affiliated to Shanxi Medical University","place":["Yuncheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-23847-0_5","article-title":"Chronic disease prevention and health promotion","volume-title":"Public Health Ethics: Cases Spanning the Globe","author":"Schmidt","year":"2016"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/07399332.2012.755980","article-title":"A study of the knowledge, attitudes, and practices (KAP) of the women referred to health centers for cardiovascular disease (CVDs) and their risk factors","volume":"35","author":"Mazloomy","year":"2014","journal-title":"Health Care For Women"},{"key":"B6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S2213-8587(22)00192-9","article-title":"World Health Assembly ratifies first global diabetes targets","volume":"10","author":"Wilkinson","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.46234\/ccdcw2021.018","article-title":"Health education in the healthy China initiative 2019-2030","volume":"3","author":"Jiang","year":"2021","journal-title":"China CDC Wkly"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.111.963553","article-title":"Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems","volume":"5","author":"Schroeder","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.amjmed.2013.02.035","article-title":"Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients","volume":"126","author":"Ji","year":"2013","journal-title":"Am J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa2032271","article-title":"Trends in diabetes treatment and control in U.S. adults, 1999-2018","volume":"384","author":"Fang","year":"2021","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2011.17.4.304","article-title":"Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes","volume":"17","author":"Vouri","year":"2011","journal-title":"J Manag Care Pharm"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3901392","article-title":"Association between Knowledge-Attitude-Practices and control of blood glucose, blood pressure, and blood lipids in patients with type 2 diabetes in Shanghai, China: A cross-sectional study","volume":"2017","author":"Yang","year":"2017","journal-title":"J Diabetes Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/nicc.70024","article-title":"Development and validation of an enteral feeding interruption management scale for ICU medical staff: A knowledge-, attitude- and practice-based approach","volume":"30","author":"Mi","year":"2025","journal-title":"Nurs Crit Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2015.09.023","article-title":"Knowledge, attitude and practices for design for safety: A study on civil & structural engineers","volume":"93","author":"Goh","year":"2016","journal-title":"Accid Anal Prev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1302274","article-title":"Development and validation of a nomogram to predict medication risk based on a knowledge, attitude and practice (KAP) survey of residents in Shanxi Province, China","volume":"15","author":"Xie","year":"2024","journal-title":"Front Pharmacol"},{"key":"B16","article-title":"Global Diabetes Compact and the WHO global diabetes coverage targets for 2030","volume-title":"World Health Organization","year":"2022"},{"key":"B17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3760\/cma.j.cn115791-20210221-00095","article-title":"Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)","volume":"13","year":"2021","journal-title":"Chin J Diabetes Mellitus"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-18","article-title":"Validation of the diabetes, hypertension and hyperlipidemia (DHL) knowledge instrument in Malaysia","volume":"12","author":"Lai","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12889-025-21622-w","article-title":"Socio-demographic and clinical determinants of self-care in adults with type 2 diabetes: a multicenter cross-sectional study in Zhejiang province, China","volume":"25","author":"Lan","year":"2025","journal-title":"BMC Public Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000330","article-title":"Determination of weight loss effectiveness evaluation indexes and establishment of a nomogram for forecasting the probability of effectiveness of weight loss in bariatric surgery: a retrospective cohort","volume":"109","author":"Lu","year":"2023","journal-title":"Int J Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2010.00740.x","article-title":"Stability selection","volume":"72","author":"Meinshausen","year":"2010","journal-title":"J R Stat Soc Ser B Stat Method"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1214\/14-AOS1221","article-title":"On asymptotically optimal confidence regions and tests for high-dimensional models","volume":"42","author":"van de G","year":"2014","journal-title":"Ann Stat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1214\/15-aos1371","article-title":"Exact post-selection inference, with application to the LASSO","volume":"44","author":"Lee","year":"2016","journal-title":"Ann Stat"},{"key":"B25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13098-023-01013-0","article-title":"The hypertension and hyperlipidemia status among type 2 diabetic patients in the community and influencing factors analysis of glycemic control","volume":"15","author":"Zhai","year":"2023"},{"key":"B26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10238-015-0406-x","article-title":"Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study","volume":"17","author":"Shan","year":"2017","journal-title":"Clin Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7596","article-title":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013","volume":"317","author":"Wang","year":"2017","journal-title":"JAMA"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1038\/s41598-019-44169-4","article-title":"The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study","volume":"9","author":"Cai","year":"2019","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12902-019-0384-1","article-title":"Factors associated with glycemic control in community-dwelling elderly individuals with type 2 diabetes mellitus in Zhejiang, China: a cross-sectional study","volume":"19","author":"Zhu","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.26599\/FMH.2025.9420061","article-title":"The effect of chitosan on blood lipids in patients with hypercholesterolemia and hyperlipidemia: a systematic review and meta-analysis","volume":"2","author":"Zhang","year":"2025","journal-title":"Food Med Homology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.26599\/FMH.2025.9420074","article-title":"Iridoid terpenoids: a class of promising compounds to regulate blood glucose","volume":"2","author":"Guo","year":"2025","journal-title":"Food Med Homology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.26599\/FMH.2025.9420068","article-title":"A review and a bibliometric analysis of tropical herbs and their bioactive compounds for modulating gut microbiota function and glucose regulation in type 2 diabetes","volume":"2","author":"Ghazaly","year":"2025","journal-title":"Food Med Homology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.26599\/FMH.2024.9420003","article-title":"The food and medicinal homological resources benefiting patients with hyperlipidemia: categories, functional components, and mechanisms","volume":"1","author":"Hao","year":"2024","journal-title":"Food Med Homology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1905392\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:16:18Z","timestamp":1788412578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1905392\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":33,"alternative-id":["10.3389\/fendo.2026.1905392"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1905392","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1905392"}}